search
Back to results

Post-operative Pain Control After Photorefractive Keratectomy Comparing Acetaminophen/Codeine vs Acetaminophen/Oxycodone

Primary Purpose

Post-operative Pain Control

Status
Completed
Phase
Phase 4
Locations
United States
Study Type
Interventional
Intervention
acetaminophen/codeine vs acetaminophen/oxycodone
Sponsored by
59th Medical Wing
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Post-operative Pain Control focused on measuring Photorefractive Keratectomy, Post-operative Eye Pain, Refractive Surgery

Eligibility Criteria

21 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • M/F >21 years of age (PRK is not done on anyone under the age of 21 at this surgery center)
  • Have met all criteria for bilateral PRK

Exclusion Criteria

  • Patients who do not meet the criteria for refractive surgery
  • Patients receiving LASIK
  • Patients known to have an allergy to either of the study pain medications
  • Patients receiving refractive surgery on only one eye
  • Pregnant women, children, military basic trainees, prisoners and detainees
  • Subject has used narcotics in the last 6 months

Sites / Locations

  • Joint Warfighter Refractive Surgery Center at WHASC

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Acetaminophen with codeine

Acetaminophen with oxycodone

Arm Description

codeine 30mg/acetaminophen 325mg Take one to two tablets every 4 to 6 hours as needed for pain for up to 4 days following surgery.

oxycodone 5mg/acetaminophen 325mg Take one tablet every 4 to 6 hours as needed for pain for up to 4 days following surgery.

Outcomes

Primary Outcome Measures

Post-operative Average Pain Score
The PRK Post-Operative Pain Survey consisted of a scale of 0 - 10 with a score of 0 equal to no pain, a score of 1 - 3 equal to mild pain, a score of 4 - 6 equal to moderate pain and a score of 7 - 10 equal to severe pain

Secondary Outcome Measures

Post-operative Uncorrected Visual Acuity Right and Left Eye
Right and left eye uncorrected visual acuity at post-operative month 6.

Full Information

First Posted
May 19, 2020
Last Updated
September 8, 2021
Sponsor
59th Medical Wing
search

1. Study Identification

Unique Protocol Identification Number
NCT04399122
Brief Title
Post-operative Pain Control After Photorefractive Keratectomy Comparing Acetaminophen/Codeine vs Acetaminophen/Oxycodone
Official Title
Post-operative Pain Control After Photorefractive Keratectomy Comparing Acetaminophen/Codeine vs Acetaminophen/Oxycodone
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
March 21, 2017 (Actual)
Primary Completion Date
October 28, 2019 (Actual)
Study Completion Date
October 28, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
59th Medical Wing

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Photorefractive keratectomy (PRK) is a refractive error correction procedure that helps eliminate or reduce the dependence on corrective lenses. An important aspect of PRK is post-operative pain management. Post-operative pain can be significant in the first three to five days and is typically controlled utilizing various modalities including narcotic pain medication. Simple observation suggests a difference in the post-operative pain levels of patients utilizing the more potent oxycodone- versus the less potent codeine-containing acetaminophen preparations. There have been no studies performed to explore any differences in perceived pain comparing these two medications when used following PRK. This study is designed to answer this question by means of a pain survey conducted in the first five days post-op. This may help better manage similar patients in the future.
Detailed Description
This will be a prospective pain assessment study utilizing a simple three question survey given to patients undergoing bilateral PRK. Following recruitment and enrollment (see section 4.1 and 4.2 for recruitment and consent process), patients will be randomized to be prescribed either 1) Group 1: codeine 30mg/acetaminophen 300mg (standard of care dosage) or 2) Group 2: oxycodone 5mg/acetaminophen 325mg (standard of care dosage) post-operatively. All post-operative patients will receive standard bandage contact lenses and as needed tetracaine as per standard of care. Patients will be removed from the study if they take other non-study pain medications. They will be asked to record their pain levels four times daily as well as the number of as needed narcotic pain medication taken and the number of tetracaine drops used (to isolate a potential confounding pain control modality). Randomization will be performed with the aid of www.randomizer.org which will generate a randomized assignment to either group 1 or group 2. All PRK procedures will be performed per standard of care. The procedure will be performed by one of the 4 approved surgeons. All surgeons will use the same technique using either the VISX or the Allegretto laser machines. This technique will include use of a brush for mechanical removal of corneal epithelial cells. The surgeons will take note at this time of the relative adherence of the epithelium to the underlying tissue and grade the adherence on a scale of 0-4 (0=least adherent and 4=most adherent). In the data analysis, differences between surgeons and between operating platform (VISX vs Allegretto) will be compared to account for any possible bias in operating parameters. The survey will be worded as follows: "Rate your eye pain or level of discomfort at 0800, 1200, 1600 and 2000. Please write the number closest to your response in the table below under the appropriate day and time. "How many tablets of study-related pain medication did you take today in the AM/PM?" "How many times did you use topical tetracaine today in the AM/PM?" "Did you take any other non-study related pain medications?" Patients will be followed-up post-operatively as per standard of care. This includes follow-up visits at 1 day, 1 week, 1 month, 3 months, 6 months and 12 months. Starting on post-operative day 1, the patients will be asked to record their pain levels using the pain survey at four hour intervals (0800, 1200, 1600, 2000). At the 1 week post-operative visit, the pain surveys will be collected from the patients. Visual acuity data will be extracted from all but the 12 month follow-up appointment and used as a secondary outcome to correlate any possible differences in pain scores to functional outcomes in terms of visual acuity.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Post-operative Pain Control
Keywords
Photorefractive Keratectomy, Post-operative Eye Pain, Refractive Surgery

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Model Description
Patients will be randomized to Group 1 or Group 2
Masking
ParticipantInvestigator
Masking Description
Randomization was accomplished by the pharmacy and the medication bottles were not labeled.
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Acetaminophen with codeine
Arm Type
Active Comparator
Arm Description
codeine 30mg/acetaminophen 325mg Take one to two tablets every 4 to 6 hours as needed for pain for up to 4 days following surgery.
Arm Title
Acetaminophen with oxycodone
Arm Type
Active Comparator
Arm Description
oxycodone 5mg/acetaminophen 325mg Take one tablet every 4 to 6 hours as needed for pain for up to 4 days following surgery.
Intervention Type
Drug
Intervention Name(s)
acetaminophen/codeine vs acetaminophen/oxycodone
Other Intervention Name(s)
Tylenol 3 VS Percocet
Intervention Description
pain medications
Primary Outcome Measure Information:
Title
Post-operative Average Pain Score
Description
The PRK Post-Operative Pain Survey consisted of a scale of 0 - 10 with a score of 0 equal to no pain, a score of 1 - 3 equal to mild pain, a score of 4 - 6 equal to moderate pain and a score of 7 - 10 equal to severe pain
Time Frame
2 days post surgery
Secondary Outcome Measure Information:
Title
Post-operative Uncorrected Visual Acuity Right and Left Eye
Description
Right and left eye uncorrected visual acuity at post-operative month 6.
Time Frame
Post-operative month 6.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: M/F >21 years of age (PRK is not done on anyone under the age of 21 at this surgery center) Have met all criteria for bilateral PRK Exclusion Criteria Patients who do not meet the criteria for refractive surgery Patients receiving LASIK Patients known to have an allergy to either of the study pain medications Patients receiving refractive surgery on only one eye Pregnant women, children, military basic trainees, prisoners and detainees Subject has used narcotics in the last 6 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Charisma B Evangelista, MD
Organizational Affiliation
59th Medical Wing
Official's Role
Principal Investigator
Facility Information:
Facility Name
Joint Warfighter Refractive Surgery Center at WHASC
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78236
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Post-operative Pain Control After Photorefractive Keratectomy Comparing Acetaminophen/Codeine vs Acetaminophen/Oxycodone

We'll reach out to this number within 24 hrs